Later on today I’ll be involved in a webinar relating to patient feasibility. You’re probably aware of the term ‘site feasibility’ and how it’s an important factor in the development of any clinical trial operations.

But you may not be so familiar with what ‘patient feasibility’ is.

I’ll be discussing the topic with Maya Zlatanova and Ilknur Lechthaler, bringing in the perspective of my experience with patient recruitment and retention.

One aspect I’m particularly interested in delving into further is how a patient feasibility assessment might be carried out, and the multiple data sources that are available for this purpose.

I’m also keen to see the sponsor perspective on how useful such an approach might be, and whether we think it can be beneficial for recruiting and retaining patients on trials.

You can watch the webinar at this URL: https://www.bigmarker.com/bioalliance-video-network/The-New-Generation-of-Clinical-Trials-Powered-by-Patient-Feasibility-and-AI

You may also like

Biotech C-suites Should keep Patient Recruitment in Mind from the Outset
In biotech, a strong C-suite isn’t just about job titles - it’s about covering every part of the journey from discovery to delivery. Including being prepared to tackle one of the biggest ...
Key C-suite Roles for Biotech Success - The Chief Patient Recruitment Officer (CPRO)
While biotech companies have built C-suites with scientific, medical, financial, operational, and business expertise, a critical function has remained conspicuously absent - addressing one ...
Key C-suite Roles for Biotech Success - The Chief Business Officer (CBO)
The Chief Business Officer leads external strategy - licensing deals, identifying pharma partnerships, and developing long-term growth planning and market positioning strategies that ...